Based on 48 hedge funds · latest filing: 2025 Q4 · updated quarterly
📈
Buying streak — 2 quarters in a row
For 2 consecutive quarters, more hedge funds added IBIO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️
At the ownership peak (100% of max)
100% of all-time peak
48 hedge funds hold IBIO right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀
Fast accumulation — +66% more funds vs a year ago
fund count last 6Q
+19 new funds entered over the past year (+66% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢
More buyers than sellers — 77% buying
37 buying11 selling
Last quarter: 37 funds were net buyers (25 opened a brand new position + 12 added to an existing one). Only 11 were sellers (3 trimmed + 8 sold completely). A clear majority buying is a strong confirmation signal.
📈
More new buyers each quarter (+19 vs last Q)
new funds entering per quarter
Funds opening a new IBIO position: 8 → 6 → 6 → 25. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌
Mixed — 25% long-term, 48% new
■ 25% conviction (2yr+)
■ 27% medium
■ 48% new
Of the 48 current holders: 12 (25%) held >2 years, 13 held 1–2 years, and 23 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💰
Value +968% but shares only +358% — price-driven
Last quarter: the total dollar value of institutional holdings rose +968%, but actual share count only changed +358%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀
Acceleration phase — new buyers rushing in
1 → 8 → 6 → 6 → 25 new funds/Q
New funds entering each quarter: 8 → 6 → 6 → 25. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
📊
Mixed cohorts — 6% veterans, 50% new entrants
■ 6% veterans
■ 44% 1-2yr
■ 50% new
Of 48 current holders: 3 (6%) held 2+ years, 21 held 1–2 years, 24 (50%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
📋
Smaller funds dominant — 13% AUM from top-100
13% from top-100 AUM funds
11 of 48 holders rank in the top 100 by AUM, but together hold only 13% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
4.9
out of 10
Moderate Exit Risk
Exit risk score 4.9/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.